V. Anik Sahni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
V. Anik Sahni has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Stuart G. Silverman
Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
5 shared publicationsKoenraad J. Mortele
From the *Division of Abdominal Imaging and Intervention, Department of Radiology, †Division of Gastroenterology, Department of Medicine, and ‡Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School; and §Divisions of Abdominal Imaging and MRI, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
4 shared publications- Sukru Mehmet Erturk
Department of Radiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Turkey
4 shared publications - Atul Bhanudas Shinagare
Department of Radiology, Brigham and Women’s Hospital, Boston, Mass
2 shared publications - Cheryl A. Sadow
Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA
2 shared publications Ramin Khorasani
Center for Evidence-Based Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 20 Kent Street, 2nd Floor, Boston, MA, 02445, USA
2 shared publications
Latest Publications
- 4 July 2017
- Published by Springer Nature in Abdominal Radiology
- Vol. 43 (3) , 663-671
Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results
Purpose To determine test characteristics of CT urography for detecting bladder cancer in patients with hematuria and those undergoing surveillance, and to analyze reasons for false-positive and false-negative results. Methods A HIPAA-compliant, IRB-approved retrospective review of reports from 1623 CT urograms between 10/2010 and 12/31/2013 was performed. 710 examinations for hematuria or bladder cancer history were compared to cystoscopy performed within 6 months. Reference standard was surgical pathology or 1-year minimum clinical follow-up. False-positive and false-negative examinations were reviewed to determine reasons for errors. Results Ninety-five bladder cancers were detected. CT urography accuracy: was 91.5% (650/710), sensitivity 86.3% (82/95), specificity 92.4% (568/615), positive predictive value 63.6% (82/129), and negative predictive value was 97.8% (568/581). Of 43 false positives, the majority of interpretation errors were due to benign prostatic hyperplasia (n = 12), trabeculated bladder (n = 9), and treatment changes (n = 8). Other causes include blood clots, mistaken normal anatomy, infectious/inflammatory changes, or had no cystoscopic correlate. Of 13 false negatives, 11 were due to technique, one to a large urinary residual, one to artifact. There were no errors in perception. Conclusion CT urography is an accurate test for diagnosing bladder cancer; however, in protocols relying predominantly on excretory phase images, overall sensitivity remains insufficient to obviate cystoscopy. Awareness of bladder cancer mimics may reduce false-positive results. Improvements in CTU technique may reduce false-negative results.
- 4 July 2017
- Published by Springer Nature in Abdominal Radiology
- Vol. 43 (3) , 663-671
Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results
Purpose To determine test characteristics of CT urography for detecting bladder cancer in patients with hematuria and those undergoing surveillance, and to analyze reasons for false-positive and false-negative results. Methods A HIPAA-compliant, IRB-approved retrospective review of reports from 1623 CT urograms between 10/2010 and 12/31/2013 was performed. 710 examinations for hematuria or bladder cancer history were compared to cystoscopy performed within 6 months. Reference standard was surgical pathology or 1-year minimum clinical follow-up. False-positive and false-negative examinations were reviewed to determine reasons for errors. Results Ninety-five bladder cancers were detected. CT urography accuracy: was 91.5% (650/710), sensitivity 86.3% (82/95), specificity 92.4% (568/615), positive predictive value 63.6% (82/129), and negative predictive value was 97.8% (568/581). Of 43 false positives, the majority of interpretation errors were due to benign prostatic hyperplasia (n = 12), trabeculated bladder (n = 9), and treatment changes (n = 8). Other causes include blood clots, mistaken normal anatomy, infectious/inflammatory changes, or had no cystoscopic correlate. Of 13 false negatives, 11 were due to technique, one to a large urinary residual, one to artifact. There were no errors in perception. Conclusion CT urography is an accurate test for diagnosing bladder cancer; however, in protocols relying predominantly on excretory phase images, overall sensitivity remains insufficient to obviate cystoscopy. Awareness of bladder cancer mimics may reduce false-positive results. Improvements in CTU technique may reduce false-negative results.
- 6 July 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 41 (11) , 2187-2195
Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes
Clear cell tubulopapillary renal cell carcinoma (CCTPRCC) is a recently described, low-grade subtype of renal cancer. We determined if imaging features could be used to distinguish early-stage CCTPRCC from stage-matched clear cell RCC (ccRCC) and papillary RCC (pRCC).
- 6 July 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 41 (11) , 2187-2195
Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes
Clear cell tubulopapillary renal cell carcinoma (CCTPRCC) is a recently described, low-grade subtype of renal cancer. We determined if imaging features could be used to distinguish early-stage CCTPRCC from stage-matched clear cell RCC (ccRCC) and papillary RCC (pRCC).
- 10 March 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 41 (3) , 429-443
The actionable imaging report
The goal of a diagnostic imaging examination is to provide the referring provider with an actionable imaging report that can be used to impart information to determine optimal clinical management for the patient. An actionable imaging report not only conveys the findings of the examination accurately, but does so in a timely and safe manner for an imaging examination that was performed appropriately and using the correct technique. The use of information technology tools has been paramount in improving the value of the imaging report and continues to play a prominent role in this process. The diversity of abdominal imaging, in both the variety of imaging modalities available and the organ systems evaluated, makes it well-suited to adopt these information technology solutions to improve report quality, including increased consistency in reports and in follow-up recommendations. This review discusses the components of the imaging chain involved in optimizing the imaging report with specific emphasis on the role of information technology applications to address the challenges that are frequently encountered. Specific abdominal imaging examples are presented to provide practical guidance and clinical context.
- 10 March 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 41 (3) , 429-443
The actionable imaging report
The goal of a diagnostic imaging examination is to provide the referring provider with an actionable imaging report that can be used to impart information to determine optimal clinical management for the patient. An actionable imaging report not only conveys the findings of the examination accurately, but does so in a timely and safe manner for an imaging examination that was performed appropriately and using the correct technique. The use of information technology tools has been paramount in improving the value of the imaging report and continues to play a prominent role in this process. The diversity of abdominal imaging, in both the variety of imaging modalities available and the organ systems evaluated, makes it well-suited to adopt these information technology solutions to improve report quality, including increased consistency in reports and in follow-up recommendations. This review discusses the components of the imaging chain involved in optimizing the imaging report with specific emphasis on the role of information technology applications to address the challenges that are frequently encountered. Specific abdominal imaging examples are presented to provide practical guidance and clinical context.
- 1 September 2015
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 205 (3) , 584-588
Impact of a Structured Report Template on the Quality of MRI Reports for Rectal Cancer Staging
OBJECTIVE. The purpose of this study is to assess the impact of implementing a structured report template on the quality of MRI reports for rectal cancer staging. MATERIALS AND METHODS. After excluding examinations performed after surgery or neoadjuvant therapy, we analyzed all rectal cancer staging MRI reports finalized at an academic medical center 12 months before and after an intervention consisting of implementing a structured report template integrated into the institution's speech recognition system. The primary outcome measure was the quality of rectal cancer staging MRI reports classified as optimal, satisfactory, or unsatisfactory, on the basis of the documentation of 14 quality measures predefined by a consensus of the institution's abdominal radiology subspecialists. Chi-square and t tests were used to assess differences in report quality and documentation of each discrete quality measure before and after the intervention. RESULTS. The study cohort included 106 MRI reports from 104 patients (m...
- 1 September 2015
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 205 (3) , 584-588
Impact of a Structured Report Template on the Quality of MRI Reports for Rectal Cancer Staging
OBJECTIVE. The purpose of this study is to assess the impact of implementing a structured report template on the quality of MRI reports for rectal cancer staging. MATERIALS AND METHODS. After excluding examinations performed after surgery or neoadjuvant therapy, we analyzed all rectal cancer staging MRI reports finalized at an academic medical center 12 months before and after an intervention consisting of implementing a structured report template integrated into the institution's speech recognition system. The primary outcome measure was the quality of rectal cancer staging MRI reports classified as optimal, satisfactory, or unsatisfactory, on the basis of the documentation of 14 quality measures predefined by a consensus of the institution's abdominal radiology subspecialists. Chi-square and t tests were used to assess differences in report quality and documentation of each discrete quality measure before and after the intervention. RESULTS. The study cohort included 106 MRI reports from 104 patients (m...
- 20 February 2014
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 31 (01) , 009-019
Imaging Management of Incidentally Detected Small Renal Masses
Both imaging and intervention play an increasingly important role in the management of renal masses in general and renal cancer in particular. Indeed, radiologists are often the first to detect and diagnose renal cancer, and now with the burgeoning role of percutaneous ablation, they are often the treating physicians. Renal mass management begins with imaging, and although most can be diagnosed with a high degree of certainty using imaging, some remain indeterminate and require biopsy or observation, now referred to as active surveillance. Although active surveillance strategies have been employed for indeterminate renal masses that have a reasonable chance of being benign, recent data suggest that some renal cancers can undergo active surveillance safely. This article reviews the current imaging-based diagnostic evaluation of incidentally detected small renal masses, the burgeoning role of percutaneous biopsy, and how both imaging and biopsy are used to help select which patients need treatment and which can undergo active surveillance.
- 20 February 2014
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 31 (01) , 009-019
Imaging Management of Incidentally Detected Small Renal Masses
Both imaging and intervention play an increasingly important role in the management of renal masses in general and renal cancer in particular. Indeed, radiologists are often the first to detect and diagnose renal cancer, and now with the burgeoning role of percutaneous ablation, they are often the treating physicians. Renal mass management begins with imaging, and although most can be diagnosed with a high degree of certainty using imaging, some remain indeterminate and require biopsy or observation, now referred to as active surveillance. Although active surveillance strategies have been employed for indeterminate renal masses that have a reasonable chance of being benign, recent data suggest that some renal cancers can undergo active surveillance safely. This article reviews the current imaging-based diagnostic evaluation of incidentally detected small renal masses, the burgeoning role of percutaneous biopsy, and how both imaging and biopsy are used to help select which patients need treatment and which can undergo active surveillance.
- 1 March 2013
- Published by Elsevier in Clinical Radiology
- Vol. 68 (3) , 264-271
Virtual unenhanced CT images acquired from dual-energy CT urography: Accuracy of attenuation values and variation with contrast material phase
- 1 March 2013
- Published by Elsevier in Clinical Radiology
- Vol. 68 (3) , 264-271
Virtual unenhanced CT images acquired from dual-energy CT urography: Accuracy of attenuation values and variation with contrast material phase
- Open Access
- 1 January 2012
- Published by E-MED LTD in Cancer Imaging
- Vol. 12 (1) , 66-71
Mucinous tubular and spindle cell carcinoma of the kidney: imaging features
Original article: Mucinous tubular and spindle cell carcinoma of the kidney: imaging features - Cancer Imaging Original article: Mucinous tubular and spindle cell carcinoma of the kidney: imaging features - This article describes the features on sonography, computed tomography (CT) and magnetic resonance imaging (MRI) of mucinous tubular and spindle cell carcinoma of the kidney. Six pathologically proven cases of mucinous tubular and spindle cell carcinoma of the kidney were identified (5 females, 1 male); all patients underwent preoperative imaging. The mean age of the patients was 58.5 years. Thirteen imaging studies were available for review: 2 sonograms, 1 unenhanced CT scan, 5 contrast-enhanced CT scans, 1 unenhanced MRI examination, and 4 contrast-enhanced MRI examinations.
- 1 January 2012
- Published by E-MED LTD in Cancer Imaging
- Vol. 12 (1) , 66-71
Open AccessMucinous tubular and spindle cell carcinoma of the kidney: imaging features
Original article: Mucinous tubular and spindle cell carcinoma of the kidney: imaging features - Cancer Imaging Original article: Mucinous tubular and spindle cell carcinoma of the kidney: imaging features - This article describes the features on sonography, computed tomography (CT) and magnetic resonance imaging (MRI) of mucinous tubular and spindle cell carcinoma of the kidney. Six pathologically proven cases of mucinous tubular and spindle cell carcinoma of the kidney were identified (5 females, 1 male); all patients underwent preoperative imaging. The mean age of the patients was 58.5 years. Thirteen imaging studies were available for review: 2 sonograms, 1 unenhanced CT scan, 5 contrast-enhanced CT scans, 1 unenhanced MRI examination, and 4 contrast-enhanced MRI examinations.
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 36 (4) , 394-399
Multidetector-Row Computed Tomography Enterographic Assessment of the Ileal-Anal Pouch
Objective To describe the multidetector-row computed tomography enterographic (MD-CTE) features of the ileal-anal pouch after ileal pouch anal anastomosis (IPAA) surgery and correlate them with pouch endoscopy and histopathologic findings. Methods All MD-CTE examinations performed on patients who underwent IPAA from July 1, 2005 to December 1, 2010 (n = 35; 16 [45.7%] men; mean age, 37.7 years; age range, 22–72 years) were retrospectively evaluated in consensus by 2 radiologists. All studies were evaluated for the presence of multiple imaging features. Two radiographic scores were then calculated: a total radiographic score and a radiographic active inflammation score. In patients who underwent MD-CTE, pouch endoscopy, and biopsy within 30 days (n = 13), both scores were correlated with findings on pouch endoscopy and histopathology. Results Of the 35 patients, 33 (94%) had at least one MD-CTE finding of active or chronic pouch inflammation and 27 patients (77%) had at least one MD-CTE finding of active pouch inflammation. Of the 13 patients who underwent endoscopy and biopsy, the total radiographic score demonstrated a strong positive correlation with endoscopic score (r = 0.81; P = 0.001) and a moderate positive correlation with histopathologic score (r = 0.56; P = 0.047). The radiographic active inflammation score demonstrated a strong positive correlation with endoscopic score (r = 0.83; P = 0.0004), but only a weak nonsignificant positive correlation with histopathologic score (r = 0.492, P = 0.087). Conclusions In patients who had IPAA surgery, findings on MD-CTE correlate positively with findings on pouch endoscopy and histopathology and are sensitive measures for pouch inflammation with high positive predictive value. Thus, MD-CTE can be a useful noninvasive test in the early evaluation of symptomatic patients.
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 36 (4) , 394-399
Multidetector-Row Computed Tomography Enterographic Assessment of the Ileal-Anal Pouch
Objective To describe the multidetector-row computed tomography enterographic (MD-CTE) features of the ileal-anal pouch after ileal pouch anal anastomosis (IPAA) surgery and correlate them with pouch endoscopy and histopathologic findings. Methods All MD-CTE examinations performed on patients who underwent IPAA from July 1, 2005 to December 1, 2010 (n = 35; 16 [45.7%] men; mean age, 37.7 years; age range, 22–72 years) were retrospectively evaluated in consensus by 2 radiologists. All studies were evaluated for the presence of multiple imaging features. Two radiographic scores were then calculated: a total radiographic score and a radiographic active inflammation score. In patients who underwent MD-CTE, pouch endoscopy, and biopsy within 30 days (n = 13), both scores were correlated with findings on pouch endoscopy and histopathology. Results Of the 35 patients, 33 (94%) had at least one MD-CTE finding of active or chronic pouch inflammation and 27 patients (77%) had at least one MD-CTE finding of active pouch inflammation. Of the 13 patients who underwent endoscopy and biopsy, the total radiographic score demonstrated a strong positive correlation with endoscopic score (r = 0.81; P = 0.001) and a moderate positive correlation with histopathologic score (r = 0.56; P = 0.047). The radiographic active inflammation score demonstrated a strong positive correlation with endoscopic score (r = 0.83; P = 0.0004), but only a weak nonsignificant positive correlation with histopathologic score (r = 0.492, P = 0.087). Conclusions In patients who had IPAA surgery, findings on MD-CTE correlate positively with findings on pouch endoscopy and histopathology and are sensitive measures for pouch inflammation with high positive predictive value. Thus, MD-CTE can be a useful noninvasive test in the early evaluation of symptomatic patients.
- 1 November 2011
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 197 (5) , 1146-1151
Feasibility of Low-Tube-Voltage Excretory Phase Images During CT Urography: Assessment Using a Dual-Energy CT Scanner
OBJECTIVE. The purpose of this study is to assess the feasibility of low-tube-voltage images during excretory phase CT urography. MATERIALS AND METHODS. In this retrospective study, we examined 70 consecutive CT urograms (35 men and 35 women; mean age, 58.5 years) performed on a dual-energy CT scanner and compared excretory phase images obtained at 80 kVp and 340 mAs with blended images (0.3 × 140 kVp and 80 mAs; and 0.7 × 80 kVp and 340 mAs). Quantitative measurements of urinary system opacification (Hounsfield units), image noise (Hounsfield units), and effective dose (millisieverts) were compared using Student paired t test. Image noise was correlated with patient thickness. Two independent blinded readers qualitatively assessed opacification, image quality (both compared using Wilcoxon test), overall acceptability (compared using McNemar test), and detectability of urinary and extraurinary findings. RESULTS. The 80-kVp images yielded significantly higher opacification of renal pelvis (p < 0.0001), ureter (p < 0.0001), bladder (p < 0.0001), and aorta (p < 0.0001); higher image noise (p < 0.0001); and lower radiation dose (5.2 vs 11.9 mSv). Image noise increased along with increasing patient thickness (r = 0.86 for 80-kVp images). Qualitative opacification scores were better only in the bladder on 80-kVp images (p = 0.002). Although 80-kVp image quality was lower (p < 0.0001), the overall acceptability was similar. Of 42 urinary findings, 40 were detected on 80-kVp images (< 2-mm calyceal calculus and tiny foci of collecting system gas were missed in one patient each, both large patients). Of 137 extraurinary findings, 130 were detected on 80-kVp images (no findings of high clinical significance were missed). CONCLUSION. Low tube voltage (80 kVp) during excretory phase CT urography is feasible, with improved urinary system opacification, acceptable image quality, and lower radiation dose.
- 1 November 2011
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 197 (5) , 1146-1151
Feasibility of Low-Tube-Voltage Excretory Phase Images During CT Urography: Assessment Using a Dual-Energy CT Scanner
OBJECTIVE. The purpose of this study is to assess the feasibility of low-tube-voltage images during excretory phase CT urography. MATERIALS AND METHODS. In this retrospective study, we examined 70 consecutive CT urograms (35 men and 35 women; mean age, 58.5 years) performed on a dual-energy CT scanner and compared excretory phase images obtained at 80 kVp and 340 mAs with blended images (0.3 × 140 kVp and 80 mAs; and 0.7 × 80 kVp and 340 mAs). Quantitative measurements of urinary system opacification (Hounsfield units), image noise (Hounsfield units), and effective dose (millisieverts) were compared using Student paired t test. Image noise was correlated with patient thickness. Two independent blinded readers qualitatively assessed opacification, image quality (both compared using Wilcoxon test), overall acceptability (compared using McNemar test), and detectability of urinary and extraurinary findings. RESULTS. The 80-kVp images yielded significantly higher opacification of renal pelvis (p < 0.0001), ureter (p < 0.0001), bladder (p < 0.0001), and aorta (p < 0.0001); higher image noise (p < 0.0001); and lower radiation dose (5.2 vs 11.9 mSv). Image noise increased along with increasing patient thickness (r = 0.86 for 80-kVp images). Qualitative opacification scores were better only in the bladder on 80-kVp images (p = 0.002). Although 80-kVp image quality was lower (p < 0.0001), the overall acceptability was similar. Of 42 urinary findings, 40 were detected on 80-kVp images (< 2-mm calyceal calculus and tiny foci of collecting system gas were missed in one patient each, both large patients). Of 137 extraurinary findings, 130 were detected on 80-kVp images (no findings of high clinical significance were missed). CONCLUSION. Low tube voltage (80 kVp) during excretory phase CT urography is feasible, with improved urinary system opacification, acceptable image quality, and lower radiation dose.
- 22 April 2011
- Published by Springer Nature in Abdominal Radiology
- Vol. 37 (1) , 110-117
Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results
Purpose To determine the utility of 3.0-Tesla diffusion-weighted (DW) magnetic resonance imaging (MRI) for focal cystic pancreatic lesion (FCPL) characterization. Materials and methods 55 FCPL (34 IPMN, 5 serous cystadenoma, and 16 inflammatory) were evaluated. Two radiologists reviewed in consensus DW-MRI images. Reference standard was obtained from patient history, cytological and histopathology data, FCPL fluid analysis, and follow-up imaging results. Signal intensity (SI) and apparent diffusion coefficient values (ADC) of FCPL and normal pancreas were measured. FCPL-to-pancreas SI and ADC ratios were also calculated. Results Qualitatively, 11 of 21 non-mucinous vs. 4 of 34 mucinous lesions appeared hyperintense at b value of 1,000 s/mm2 (P = 0.02). Three FCPL demonstrated restricted diffusion: all inflammatory. Significant differences in mean ADC between neoplastic vs. non-neoplastic (P = 0.009), and mucinous vs. non-mucinous (P = 0.013) lesions were demonstrated. FCPL-to-pancreas ADC and SI ratios demonstrated significant differences between neoplastic vs. non-neoplastic lesions [ADC, (P = 0.019); SI for b values 750 (P = 0.010) and 1,000 s/mm2 (P = 0.017)] and mucinous vs. non-mucinous lesions [ADC (P = 0.018); SI for b values 750 (P = 0.013) and 1,000 s/mm2 (P = 0.015)]. Conclusion Although mean ADC values and FCPL-to-pancreas SI and ADC ratios may be helpful in differentiating FCPL, characterization of individual FCPL by means of 3.0-Tesla DW-MRI appears limited.
- 22 April 2011
- Published by Springer Nature in Abdominal Radiology
- Vol. 37 (1) , 110-117
Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results
Purpose To determine the utility of 3.0-Tesla diffusion-weighted (DW) magnetic resonance imaging (MRI) for focal cystic pancreatic lesion (FCPL) characterization. Materials and methods 55 FCPL (34 IPMN, 5 serous cystadenoma, and 16 inflammatory) were evaluated. Two radiologists reviewed in consensus DW-MRI images. Reference standard was obtained from patient history, cytological and histopathology data, FCPL fluid analysis, and follow-up imaging results. Signal intensity (SI) and apparent diffusion coefficient values (ADC) of FCPL and normal pancreas were measured. FCPL-to-pancreas SI and ADC ratios were also calculated. Results Qualitatively, 11 of 21 non-mucinous vs. 4 of 34 mucinous lesions appeared hyperintense at b value of 1,000 s/mm2 (P = 0.02). Three FCPL demonstrated restricted diffusion: all inflammatory. Significant differences in mean ADC between neoplastic vs. non-neoplastic (P = 0.009), and mucinous vs. non-mucinous (P = 0.013) lesions were demonstrated. FCPL-to-pancreas ADC and SI ratios demonstrated significant differences between neoplastic vs. non-neoplastic lesions [ADC, (P = 0.019); SI for b values 750 (P = 0.010) and 1,000 s/mm2 (P = 0.017)] and mucinous vs. non-mucinous lesions [ADC (P = 0.018); SI for b values 750 (P = 0.013) and 1,000 s/mm2 (P = 0.015)]. Conclusion Although mean ADC values and FCPL-to-pancreas SI and ADC ratios may be helpful in differentiating FCPL, characterization of individual FCPL by means of 3.0-Tesla DW-MRI appears limited.